Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01618903
What this trial is testing

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Who this might be right for
Human Volunteers
UCB Pharma 24
Testing effectiveness (Phase 2)Study completedNCT04162769
What this trial is testing

Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Arena Pharmaceuticals 140
Early research (Phase 1)Study completedNCT01738451
What this trial is testing

Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors

Who this might be right for
Cancer
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07281495
What this trial is testing

Taldefgrobep Alfa in Adults With Overweight and Obesity

Who this might be right for
ObesityOverweight
Biohaven Therapeutics Ltd. 150
Early research (Phase 1)Study completedNCT01223339
What this trial is testing

Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 24
Large-scale testing (Phase 3)Study completedNCT02963766
What this trial is testing

Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 154
Large-scale testing (Phase 3)Active Not RecruitingNCT06741228
What this trial is testing

Trial of DT120 for Generalized Anxiety Disorder (Voyage)

Who this might be right for
Generalized Anxiety Disorder
Definium Therapeutics US, Inc. 214
Early research (Phase 1)Study completedNCT02175056
What this trial is testing

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

Who this might be right for
Healthy Volunteers
Handok Inc. 58
Large-scale testing (Phase 3)Study completedNCT01624675
What this trial is testing

Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder

Who this might be right for
Autistic Disorder in Children and Adolescents
Janssen Pharmaceutical K.K. 39
Testing effectiveness (Phase 2)Study completedNCT03369236
What this trial is testing

A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)

Who this might be right for
C3 GlomerulopathyC3 GlomerulonephritisDense Deposit Disease
Alexion Pharmaceuticals, Inc. 13
Early research (Phase 1)Study completedNCT01487460
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

Who this might be right for
DyslipidemiaHealthy Volunteers
Novartis Pharmaceuticals 137
Not applicableLooking for participantsNCT07754175
What this trial is testing

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Who this might be right for
Knee Osteoarthritis
Kang Stem Biotech Co., Ltd. 36
Large-scale testing (Phase 3)Ended earlyNCT04248465
What this trial is testing

An Efficacy and Safety Study of Ravulizumab in ALS Participants

Who this might be right for
Amyotrophic Lateral SclerosisALS
Alexion Pharmaceuticals, Inc. 382
Testing effectiveness (Phase 2)WithdrawnNCT05198362
What this trial is testing

Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome

Who this might be right for
Prader-Willi Syndrome
Saniona
Early research (Phase 1)Study completedNCT01843127
What this trial is testing

Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 24
Large-scale testing (Phase 3)Looking for participantsNCT07213960
What this trial is testing

A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
FSGS
Apellis Pharmaceuticals, Inc. 270
Testing effectiveness (Phase 2)Study completedNCT03692910
What this trial is testing

Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Who this might be right for
Bipolar Disorder IBipolar Disorder IIMajor Depressive Episode
Biogen 35
Large-scale testing (Phase 3)Temporarily pausedNCT05463679
What this trial is testing

Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.

Who this might be right for
Vascular Ehlers-Danlos Syndrome
Aytu BioPharma, Inc. 260
Testing effectiveness (Phase 2)Ended earlyNCT00993018
What this trial is testing

Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy

Who this might be right for
Diabetic Neuropathy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 77
Early research (Phase 1)Study completedNCT03258515
What this trial is testing

Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

Who this might be right for
Solid Tumors
AstraZeneca 45
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation